{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T05:57:39Z","timestamp":1719640659900},"reference-count":13,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":5783,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Liver Transpl"],"published-print":{"date-parts":[[1999,11]]},"DOI":"10.1002\/lt.500050611","type":"journal-article","created":{"date-parts":[[2004,7,28]],"date-time":"2004-07-28T07:20:58Z","timestamp":1090999258000},"page":"502-508","source":"Crossref","is-referenced-by-count":16,"title":["Tacrolimus rescue in liver transplant patients with refractory rejection or intolerance or malabsorption of cyclosporine"],"prefix":"10.1002","volume":"5","author":[{"given":"Andrew","family":"Klein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,12,30]]},"reference":[{"key":"10.1002\/lt.500050611-BIB1|cit1","first-page":"4","article-title":"Discovery of FK506, a novel immunosuppressant isolated from Streptomyces tsukubaensis","volume":"19","author":"Goto","year":"1987","journal-title":"Transplant Proc"},{"key":"10.1002\/lt.500050611-BIB2|cit2","first-page":"2713","article-title":"FK506: Historical perspectives","volume":"23","author":"Goto","year":"1991","journal-title":"Transplant Proc"},{"key":"10.1002\/lt.500050611-BIB3|cit3","first-page":"36","article-title":"Effect of FK506 on human mixed lymphocyte reaction in vitro","volume":"19","author":"Kino","year":"1987","journal-title":"Transplant Proc"},{"key":"10.1002\/lt.500050611-BIB4|cit4","first-page":"3017","article-title":"FK506 in solid organ transplantation","volume":"26","author":"Fung","year":"1994","journal-title":"Transplant Proc"},{"key":"10.1002\/lt.500050611-BIB5|cit5","first-page":"3005","article-title":"FK506 used as rescue therapy for human liver allograft recipients","volume":"23","author":"Demetris","year":"1991","journal-title":"Transplant Proc"},{"key":"10.1002\/lt.500050611-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1097\/00007890-199205000-00017","article-title":"Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy-A clinicopathologic study of 96 patients","volume":"53","author":"Demetris","year":"1992","journal-title":"Transplantation"},{"key":"10.1002\/lt.500050611-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1097\/00007890-199306000-00022","article-title":"Differences in oral FK506 dose requirements between adult and pediatric liver transplant patients","volume":"55","author":"McDiarmid","year":"1993","journal-title":"Transplantation"},{"key":"10.1002\/lt.500050611-BIB8|cit8","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/00007890-199302000-00011","article-title":"Experience with FK506 in living-related liver transplantation","volume":"55","author":"Uemoto","year":"1993","journal-title":"Transplantation"},{"key":"10.1002\/lt.500050611-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1097\/00007890-199404270-00005","article-title":"FK506 conversion therapy in pediatric liver transplantation","volume":"57","author":"Egawa","year":"1994","journal-title":"Transplantation"},{"key":"10.1002\/lt.500050611-BIB10|cit10","first-page":"423","article-title":"Randomized trial comparing tracrolimus (FK506) and cyclosporin in prevention of liver allograft rejection","volume":"334","author":"European FK506 Multicentre Liver Study Group","year":"1994","journal-title":"Lancet"},{"key":"10.1002\/lt.500050611-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1056\/NEJM199410273311702","article-title":"A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression in liver transplantation","volume":"331","author":"The US Multicenter FK506 Liver Study Group","year":"1994","journal-title":"N Engl J Med"},{"issue":"suppl 1","key":"10.1002\/lt.500050611-BIB12|cit12","first-page":"38","article-title":"Risk factors and pathogenesis of posttransplant lymphoproliferative disorders","volume":"27","author":"Ho","year":"1995","journal-title":"Transplant Proc"},{"key":"10.1002\/lt.500050611-BIB13|cit13","first-page":"1400","article-title":"Posttransplant lymphoproliferative disorders in liver recipients treated with OKT3 or ALG induction immunosuppression","volume":"25","author":"McAlister","year":"1993","journal-title":"Transplant Proc"}],"container-title":["Liver Transplantation and Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Flt.500050611","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/lt.500050611","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T16:04:36Z","timestamp":1625501076000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/lt.500050611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,11]]},"references-count":13,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1999,11]]}},"URL":"https:\/\/doi.org\/10.1002\/lt.500050611","relation":{},"ISSN":["1074-3022"],"issn-type":[{"value":"1074-3022","type":"print"}],"subject":[],"published":{"date-parts":[[1999,11]]}}}